Rabomil-DSR, combining enteric-coated Rabeprazole 20 mg and sustained-release Domperidone 30 mg, offers dual-action protection against stomach acid-related issues. Rabeprazole provides the fastest acid suppression, aiding in H. pylori eradication and ulcer healing, while Domperidone enhances gastrointestinal motility, relieves nausea, and increases LES pressure. This combination effectively treats conditions like gastritis, hyperacidity, peptic ulcers, and GERD, ensuring comprehensive and round-the-clock relief from symptoms.